- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04163003
Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents (TAPAS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
General Description:
This study has two sub-studies: one for youth who experience behaviorally insufficient sleep syndrome (BISS) and one for youth who obtain sufficient sleep. This includes a randomized controlled trial for youth who obtain insufficient sleep (BISS), and a universal education (UE) only intervention for youth who obtain sufficient sleep.
All participants will complete a pre-consent screen. Those with sufficient sleep will complete consent/assent and a full screening assessment, and they will watch a sleep education video (UE). If eligible for the sufficient sleeper study, the full screening assessment will serve as a baseline assessment as well. Participants will complete a follow-up assessment about one month later.
Those who pre-screen as insufficient sleepers will complete consent/assent, complete a full screening process, and watch a sleep education video (UE). Those who remain eligible after the full screening process will complete a baseline assessment. Then, youth will be randomized to the TAPAS intervention or to a wait-list control (monitoring only). After completing the post-period 1 follow-up assessment, those in the wait-list control group will switch to the other arm, via a cross-over design. Participants in the intervention-first group will continue to receive the intervention iin Period 2 after post-period 1. After this period, participants will complete the post-period 2 follow-up assessment.
Detailed Description:
Participants. Youth ages 13-15 will be recruited through various methods (e.g., social media advertising, University research registry, flyers, email listservs and online magazines, and from the waiting room of the Children's Hospital of Pittsburgh Center for Adolescent and Young Adult Health (CAYAH)). Among those screened, the investigators will deliver universal education about sleep and conduct baseline and follow-up assessments among n=35 sufficient sleepers. Investigators will randomize n=50 with insufficient sleep to the TAPAS intervention or wait-list control (monitoring only). Overall, investigators plan to collect complete data on n=40 participants, after attrition.
Baseline assessments will include: measures of sleep (sleep diary and actigraphy), academic functioning, attention, affect, motivation, and risk behavior.
TAPAS Intervention. Program goals are to increase knowledge about healthy sleep practices, to increase sleep duration by going to bed earlier (sleep extension), and to increase regularity in sleep timing over the week by limiting oversleeping on the weekends. During the 45-60 minute intervention session, the youth and clinician will discuss the youth's sleep timing and quality and explore the youth's attitudes and social influences on sleep. The clinician will develop discrepancies between current sleep behavior and the youth's values and goals.
It is proposed that the 4-8-week text messaging/web-based portion of the intervention will begin immediately after the clinician session. Participants will receive twice-weekly summaries of their sleep based on diary entries. Participants will then be asked via the web if they'd like to modify their sleep, providing them with autonomy in their answer. Investigators will rely on strategies for extending and regularizing sleep.
Wait-List Control (monitoring only) Condition. The wait-list is proposed to last half the duration as the targeted intervention (4 vs 8 weeks). Participants will monitor sleep with the sleep diary, but they will not receive feedback or any other information on their sleep.
Participants will repeat the baseline assessments and 7 days of actigraphy at the end of Period 1 and at the end of Period 2 (only those randomized to Wait-List Control will cross-over to TAPAS intervention for Period 2).
Follow-up assessments will include: measures of sleep (sleep diary and actigraphy), academic functioning, attention, affect, motivation, and risk behavior.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
All participants will be excluded if they live more than roughly an hour's drive from Pittsburgh, Pennsylvania (PA).
Insufficient Sleepers:
Investigators will screen, deliver universal education (UE), and offer participation to all participants:
- ages 13 years, 0 months to 15 years, 11 months;
- able and willing to give informed assent to participate (with informed consent from parent);
- insufficient sleep (≤7.5 hours sleep on average weeknights); and
- weekend-weekday sleep timing shift >=1.5 hours.
Inclusion criteria are not applicable for parents.
Exclusion Criteria:
- Evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder will exclude potential participants;
- unstable medical conditions;
- use of psychotropic medications or medications known to impact sleep;
- adolescent pregnancy;
- clinical levels of psychopathology, except for youth with a sole diagnosis of gender dysphoria;
- current sleep disorders except for sleep-onset insomnia;
- extreme evening preference; and
- Currently living >1 hour outside of the greater Pittsburgh region.
Sufficient Sleepers:
Inclusion Criteria:
- ages 13-15;
- sufficient sleep (>7.5 hours of sleep);
- willing/able to provide informed assent/consent.
Exclusion Criteria:
- Evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder;
- unstable medical conditions;
- use of psychotropic medications or medications known to impact sleep;
- adolescent pregnancy;
- clinical levels of psychopathology, except for youth with a sole diagnosis of gender dysphoria;
- current sleep disorders except for sleep-onset insomnia;
- extreme evening preference; and
- Currently living >1 hour outside of the greater Pittsburgh region.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: TAPAS
Participants will participate in the TAPAS intervention, which will consist of one in-person engagement session with a therapist and 8 weeks of web-based automated intervention prompts.
The program will utilize empirically supported approaches for promoting sleep health, delivered in-person and via text-message, focusing on: tailored psychoeducation, motivation and efficacy to change sleep, extending sleep duration, and regularizing sleep timing across the week.
|
The targeted intervention is a three part sleep program, involving a 2- minute psychoeducation video, an in-person session with a clinician focusing on sleep, and web-based goal setting related to sleep behaviors.
Intervention approaches to promoting adolescent sleep and reducing insufficient sleep use a motivational interviewing style, rooted in cognitive-behavioral strategies for improving sleep.
Other Names:
|
|
EXPERIMENTAL: Sleep monitoring only, then TAPAS
Participants will participate in sleep monitoring only first, then participate in the TAPAS intervention.
First, participants will monitor sleep with sleep diary, but they will not receive feedback or any other information on to sleep.TAPAS will consist of one engagement session with a therapist and 4 weeks of web-based automated intervention prompts.
The program will utilize empirically supported approaches for promoting sleep health, delivered in-person and via text-message, focusing on: tailored psychoeducation, motivation and efficacy to change sleep, extending sleep duration, and regularizing sleep timing across the week.
Sleep monitoring is proposed to last the same duration as the targeted intervention in this arm.
|
The targeted intervention is a three part sleep program, involving a 2- minute psychoeducation video, an in-person session with a clinician focusing on sleep, and web-based goal setting related to sleep behaviors.
Intervention approaches to promoting adolescent sleep and reducing insufficient sleep use a motivational interviewing style, rooted in cognitive-behavioral strategies for improving sleep.
Other Names:
Participants will monitor sleep with sleep diary, but they will not receive feedback or any other information on to sleep.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attrition
Time Frame: 4 weeks
|
Participant attrition rate
|
4 weeks
|
|
Response Rate
Time Frame: 4 weeks
|
Participant response rate to electronic intervention prompts
|
4 weeks
|
|
Adherence
Time Frame: 1 session
|
A locally-developed Sleep Promotion Program Rating form indicates which program components covered in each clinician session.
The measure is a checklist that indicates the presence or absence of each component covered in the session.
|
1 session
|
|
Participant Satisfaction
Time Frame: 4 weeks
|
A locally-developed Treatment Satisfaction Questionnaire measures program satisfaction.
Scores range from 18 to 75, with higher scores indicating greater satisfaction.
|
4 weeks
|
|
Sleep Diary Sleep Duration
Time Frame: 4 weeks
|
Average sleep duration (in hours and minutes) as measured by sleep diary
|
4 weeks
|
|
Sleep Diary Sleep Timing
Time Frame: 4 weeks
|
Average sleep timing as measured by sleep diary
|
4 weeks
|
|
Sleep Diary Weekend-Weekday Sleep Timing Differences
Time Frame: 4 weeks
|
Difference in average weekend and weekday sleep timing as measured by sleep diary
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Actigraphy Sleep Duration
Time Frame: 4 weeks
|
Average sleep duration (in hours and minutes) as measured by actigraphy
|
4 weeks
|
|
Actigraphy Sleep Timing
Time Frame: 4 weeks
|
Average sleep timing as measured by actigraphy
|
4 weeks
|
|
Actigraphy Weekend-Weekday Sleep Timing Differences
Time Frame: 4 weeks
|
Differences in average weekend and weekday sleep timing as measured by actigraphy
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Academic Functioning
Time Frame: 4 weeks
|
Grades in School
|
4 weeks
|
|
Attention
Time Frame: 4 weeks
|
The Psychomotor Vigilance Test (PVT) is a computer-based test of vigilant attention, which is measured by reaction time in milliseconds.
|
4 weeks
|
|
Affect
Time Frame: 4 weeks
|
The Mood and Feelings Questionnaire (MFQ) is a measure or depressive symptoms.
Scores range from 0 to 66, with higher scores indicating greater depressive symptoms.
|
4 weeks
|
|
Risk Behavior
Time Frame: 4 weeks
|
The Balloon Analogue Risk Task (BART) is a computerized measure of risk-taking behavior.
In the task, the participant can earn money by pumping up balloons.
Each pump incrementally results in a larger balloon and an associated increase in earn money.
However, popping a balloon results in loss of money.
Each balloon pops at a different point.
The primary outcome is average number of pumps on unexploded balloons, with higher scores indicative of greater risk-taking propensity
|
4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jessica C Levenson, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY19080033
- K23HD087433 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disturbance
-
Università degli Studi di BresciaCompletedSleep Phase Rhythm DisturbanceItaly
-
Zhuan ZhangNot yet recruitingCircadian Rhythm | Postoperative Sleep DisturbanceChina
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruitingPostoperative Sleep Disturbance
-
Our Lady's Hospice and Care ServicesSt Vincent's University Hospital, IrelandEnrolling by invitation
-
University of BergenGlamoxCompletedSleep | Sleep Deprivation | Shift-Work Related Sleep DisturbanceNorway
-
Riphah International UniversityCompletedSleep Disturbance in AthletesPakistan
-
Sam Houston State UniversityThe University of Texas Health Science Center, Houston; Memorial Hermann Texas...CompletedSleep Disturbance in Hospitalized Antepartum PatientsUnited States
-
Erasmus Medical CenterNational Institute for Public Health and the Environment (RIVM); Netherlands...CompletedShift-Work Related Sleep DisturbanceNetherlands
-
Pacific UniversityCompletedInsomnia | Shift-Work Related Sleep DisturbanceUnited States
-
Seoul National University HospitalNot yet recruiting
Clinical Trials on Targeted Approaches for Promoting Adolescent Sleep (TAPAS)
-
Seattle Children's HospitalUniversity of VirginiaActive, not recruitingMigraine Disorders | Insomnia | Headache DisordersUnited States
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of Medicine; National Institute of Chemistry... and other collaboratorsCompletedCTNNB1 Gene MutationSlovenia, Australia
-
University Medical Centre LjubljanaThe University of New South Wales; University of Ljubljana School of Medicine... and other collaboratorsRecruitingCTNNB1 Neurodevelopmental SyndromeSlovenia, Australia